首页> 美国卫生研究院文献>Journal of Clinical Research in Pediatric Endocrinology >Early Onset of Liver Steatosis in a Japanese Girl with Maturity-Onset Diabetes of the Young Type 3 (MODY3)
【2h】

Early Onset of Liver Steatosis in a Japanese Girl with Maturity-Onset Diabetes of the Young Type 3 (MODY3)

机译:日本女孩患有年轻的3型糖尿病(MODY3)的肝脏脂肪变性的早期发作。

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Maturity-onset diabetes of the young type 3 (MODY3) is caused by heterozygous mutation in the HNF1A gene. Liver adenomatosis has been reported in MODY3 patients. The patient reported in this paper is a Japanese girl who first developed hepatomegaly, fatty liver, and hepatic dysfunction at age 5 years. Liver biopsy demonstrated steatosis and degeneration of hepatocytes. At that time, blood glucose and HbA1c levels were within normal ranges. Elevated HbA1c was noticed 4 years later, but islet cell and glutamic acid decarboxylase antibodies were not detected in the serum. Therefore, MODY3 was suspected and subsequent analysis of the HNF1A gene identified a heterozygous germline splice donor-site mutation in intron 9. MODY3 patients should be screened by non-invasive liver imaging, and careful follow-up of liver disease should be performed. >Conflict of interest:None declared.
机译:HNF1A基因杂合突变引起年轻的3型成熟性糖尿病(MODY3)。据报道,MODY3患者存在肝腺瘤病。本文报道的患者是一名日本女孩,该女孩最初在5岁时出现肝肿大,脂肪肝和肝功能障碍。肝活检显示肝细胞脂肪变性和变性。那时,血糖和HbA1c水平在正常范围内。 4年后发现HbA1c升高,但在血清中未检测到胰岛细胞和谷氨酸脱羧酶抗体。因此,怀疑是MODY3,随后对HNF1A基因的分析在内含子9中鉴定出杂合的种系剪接供体位点突变。应通过无创肝成像对MODY3患者进行筛查,并对肝病进行认真的随访。 >利益冲突:未声明。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号